Our results showed that the haplotype frequency of HLA-B*1301~C*0304 in PSS patients was significantly lower than that in controls PSS (OR = 0.23; 95% CI: 0.08–0.68; Table 4), indicating that individuals carrying this haplotype might have a reduced risk to develop PSS. The gene discussed is HLA-B; the disease is peeling skin syndrome.